Jagsonpal Pharmaceuticals Share Price
Know More₹657.80-35.25 (-5.09%)
20-Dec-2024₹657.60-30.70 (-4.46%)
20-Dec-2024BSE : 507789
NSE : JAGSNPHARM
Sector : Health care
ISIN Code : INE048B01027
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 20-Dec-2024
| Market Cap (₹ Cr) | 1,746 |
Traded Value (₹ Cr) | 0.57 |
Volume (Shares) | 8,629 |
Face Value (₹) | 5 |
52-Week High (₹) | 820.05 |
52-Week High Date | 29-Nov-2024 |
52-Week Low (₹) | 270.05 |
52-Week Low Date | 14-Mar-2024 |
All Time High (₹) | 820.05 |
All Time High Date | 29-Nov-2024 |
All Time Low (₹) | 1.38 |
All Time Low Date | 18-Oct-1991 |
Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharma News
Jagsonpal Pharma Announcement
Jagsonpal Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,745 |
| EPS - TTM (₹) [S] | 10.08 |
| P/E Ratio (X) [S] | 65.24 |
| Face Value (₹) | 5 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 06-Sep-2024 |
| Dividend Yield (%) | 0.76 |
| Book Value Share (₹) [S] | 74.26 |
| P/B Ratio (₹) [S] | 8.86 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| WhiteOak Capital Pharma and Healthcare Fund-Reg (G) | 1.23 | 29,568 | 0.61 |
| WhiteOak Capital Pharma and Healthcare Fund-Dir (G) | 1.23 | 29,568 | 0.61 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 654.00 698.40 |
| Week Low/High (₹) | 647.45 730.00 |
| Month Low/High (₹) | 566.35 820.00 |
| Year Low/High (₹) | 273.60 820.00 |
| All time Low/High (₹) | 1.38 820.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -2.51% | -2.21% | -4.98 | -4.77% |
| 1 Month | 13.75% | 14.05% | 0.60 | 0.29% |
| 3 Month | 61.04% | 60.33% | -7.69 | -8.54% |
| 6 Month | 94.35% | 94.47% | 0.73 | 0.09% |
| 1 Year | 73.90% | 74.24% | 10.69 | 11.52% |
| 3 Year | 322.22% | 322.89% | 39.80 | 41.97% |
Company Info
Company Information
Managing Director : Manish Gupta
Chairman & Non Executive Dir. : Harsha Raghavan
Independent Director : Debasis Bikash Nandy
Independent Director : Radhika Dudhat
Independent Director : Pallavi Dinodia
Non Executive Director : Prithipal Singh Kochhar
Company Sec. & Compli. Officer : Abhishek Joshi
Registered Office: T-210 J, Shahpur Jat,New Delhi,New Delhi-110049 Ph: 91-011-46181100/46109900
FAQs about Jagsonpal Pharmaceuticals Ltd
1. What's the Jagsonpal Pharmaceuticals Ltd share price today?
Jagsonpal Pharmaceuticals Ltd share price was Rs 657.80 at close on 20th Dec 2024. Jagsonpal Pharmaceuticals Ltd share price was down by 5.09% from the previous closing price of Rs 693.05. Jagsonpal Pharmaceuticals Ltd share price trend:
- Last 1 Month: Jagsonpal Pharmaceuticals Ltd share price moved up by 13.75% on BSE
- Last 3 Months: Jagsonpal Pharmaceuticals Ltd share price moved up by 61.04% on BSE
- Last 12 Months: Jagsonpal Pharmaceuticals Ltd share price moved up by 73.90% on BSE
- Last 3 Years: Jagsonpal Pharmaceuticals Ltd price moved up by 322.22% on BSE
2. How can I quickly analyse the performance of the Jagsonpal Pharmaceuticals Ltd stock?
The performance of the Jagsonpal Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 65.24
- Price to book value ratio is 8.86
- Dividend yield of 0.76
- The EPS (trailing 12 months) of the Jagsonpal Pharmaceuticals Ltd stock is Rs 10.08
3. What is the market cap of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of Rs 1,746 crore.
4. What is Jagsonpal Pharmaceuticals Ltd's 52-week high/low share price?
The Jagsonpal Pharmaceuticals Ltd’s 52-week high share price is Rs 820.05 and 52-week low share price is Rs 270.05.
5. Is the Jagsonpal Pharmaceuticals Ltd profitable?
On a consolidated basis, Jagsonpal Pharmaceuticals Ltd reported a profit of Rs 11.46 crore on a total income of Rs 76.34 crore for the quarter ended 2024. For the year ended Sep 2024, Jagsonpal Pharmaceuticals Ltd had posted a profit of Rs 11.46 crore on a total income of Rs 76.35 crore.
6. Which are Jagsonpal Pharmaceuticals Ltd’s peers in the Health care sector?
Jagsonpal Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Hester Bios, SMS Pharma., Syncom Formul., Jagsonpal Pharma, Sigachi Indust., Bliss GVS Pharma, Bajaj Healthcare.
7. Who owns how much in Jagsonpal Pharmaceuticals Ltd?
Key changes to the Jagsonpal Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Jagsonpal Pharmaceuticals Ltd has gone down to 67.97 per cent as of Sep 2024 from 68.48 per cent as of Dec 2023.
